Evidence map›Paper›PMID 30293577›Full record

ArticleMolecular metabolism2018

Maternal exercise intervention in obese pregnancy improves the cardiovascular health of the adult male offspring.

Jessica H Beeson, Heather L Blackmore, Sarah K Carr, Laura Dearden, Daniella E Duque-Guimarães, Laura C Kusinski, Lucas C Pantaleão, Adele G Pinnock, Catherine E Aiken, Dino A Giussani and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum.American journal of physiology. Heart and circulatory physiology · 2024
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. [Obesity during pregnancy is associated to congenital cardiopathies in the newborn].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. The role of microRNAs in pregnancies complicated by maternal diabetes.Clinical science (London, England : 1979) · 2024
    Review
  19. Article
  20. Early life impacts of maternal obesity: a window of opportunity to improve the health of two generations.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jessica H BeesonUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: jhb54@cam.ac.uk.
Heather L BlackmoreUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: hlb46@cam.ac.uk.
Sarah K CarrUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: blondesarah20@gmail.com.
Laura DeardenUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: ld454@medschl.cam.ac.uk.
Daniella E Duque-GuimarãesUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: dd414@medschl.cam.ac.uk.
Laura C KusinskiUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: lck34@medschl.cam.ac.uk.
Lucas C PantaleãoUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: lp435@medschl.cam.ac.uk.
Adele G PinnockUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: apinnock201@gmail.com.
Catherine E AikenUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK; Department of Obstetrics and Gynaecology, University of Cambridge, The Rosie Hospital and NIHR Cambridge Comprehensive Biomedical Research Centre, Box 223, Cambridge, CB2 0SW, UK. Electronic address: catherineaiken@gmail.com.
Dino A GiussaniDepartment of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, CB2 3EG, UK. Electronic address: dag26@cam.ac.uk.
Denise S Fernandez-TwinnUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: df220@cam.ac.uk.
Susan E OzanneUniversity of Cambridge, Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Level 4, Box 289, Hills Road, Cambridge, CB2 0QQ, UK. Electronic address: seo10@cam.ac.uk.
University of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E002668/1British Heart Foundation FS/09/029/27902British Heart Foundation FS/12/74/29778British Heart Foundation PG/10/99/28656British Heart Foundation PG/13/46/30329British Heart Foundation PG/14/20/30769British Heart Foundation PG/14/5/30547British Heart Foundation RG/06/006/22028British Heart Foundation RG/11/16/29260British Heart Foundation RG/17/12/33167British Heart Foundation RG/17/8/32924Medical Research Council MC_UU_00014/4Medical Research Council MC_UU_12012/4
6 · The paper itself

Abstract

objectiveObesity during pregnancy is associated with an elevated risk of cardiovascular disease in the offspring. With increased numbers of women entering pregnancy overweight or obese, there is a requirement for targeted interventions to reduce disease risk in future generations. Using an established murine model of maternal obesity during pregnancy, we investigated if a treadmill exercise intervention in the mother could improve offspring cardiac health and explored potential underlying mechanisms.

methodsA 20-minute treadmill exercise intervention protocol was performed 5 days a week in diet-induced obese female C57BL/6 mice 1 week prior to, and up to E17 of pregnancy. All male offspring were weaned onto a control diet and studied at 8 weeks of age when their cardiovascular physiology was assessed by in vivo echocardiography and non-invasive tail cuff plethysmography. Cardiomyocyte cell area, re-expression of fetal genes and the expression of calcium handling and sympathetic activation proteins were determined.

resultsAt 8 weeks, there was no difference in bodyweight or fat mass between groups. Offspring of obese dams developed pathologic cardiac hypertrophy, hypertension and cardiac dysfunction characterized by reduced ejection fraction (p < 0.001). Maternal exercise prevented cardiac hypertrophy and dysfunction but failed to prevent hypertension. These offspring of exercised dams also had enhanced (p < 0.001) levels of calcium handling proteins and a sympathetic-activated inotropic response.

conclusionsExercise in obese pregnancy was beneficial to offspring cardiac function and structure but did not influence hypertension suggesting they are programmed by separate mechanistic pathways. These data suggest combination interventions in obese pregnancies will be required to improve all aspects of the cardiovascular health of the next generation.

Indexed as

AdiposityAnimalsBody CompositionBody WeightCardiovascular Physiological PhenomenaDietExercise TherapyFemaleLactationMaleMiceMice, Inbred C57BLObesityOverweightPhysical Conditioning, AnimalPhysical ExertionEchocardiographyExerciseHypertrophyObesityPregnancy

Identifiers

PMID30293577
PMCPMC6157615
OpenAlexW2809354242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.